Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Olympus Corp. (JP:7733)
:7733
Holding JP:7733?
Track your performance easily
Earnings Data
Report Date
Feb 07, 2025TBA Not Confirmed
Period Ending
2025 (Q3)Consensus EPS Forecast
35.82Last Year’s EPS
17.78Same Quarter Last Year
Strong Buy
Based on 3 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 06, 2018
|% Change Since: -15.09%
|Next Earnings Date:Aug 07, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a strong financial performance with significant revenue and profit growth, particularly in North America. However, the resignation of the CEO amid allegations and challenges in China and other markets posed notable concerns. The overall sentiment is balanced by robust operational achievements and strategic advancements, such as AI medical device approvals.Company Guidance
During the Q2 2025 earnings call for 7733.T, the company reported a 10% year-over-year revenue increase to JPY 474 billion, bolstered by yen depreciation and strong North American performance, achieving 24% growth across its gastrointestinal (GI), urology, and respiratory segments. Adjusted operating profit surged 28% to JPY 85.1 billion, with a margin improvement of 2.5 points to 17.9%. The Elevate program, aimed at meeting U.S. FDA commitments, showed progress, with over 95% of commitments completed. The company remains on track with its financial guidance despite uncertainties, maintaining a full-year forecast unchanged. Additionally, notable developments included receiving U.S. and European clearances for cloud-based AI endoscopy devices, which are expected to enhance clinical outcomes and operational efficiency. The call also addressed challenges in China and outlined efforts to harmonize global complaint handling processes.Revenue Growth and Record Highs
Consolidated revenue increased by 10% year-over-year to JPY 474 billion, with significant growth in North America (24% year-to-year growth). Revenue reached a record high for Q2 and for the sixth month.
Operating Profit Increase
Operating profit increased significantly year-on-year to JPY 70.5 billion. Adjusted operating profit increased by 28% year-on-year to JPY 85.1 billion, with an adjusted operating margin improving 2.5 points to 17.9%.
AI Medical Devices Approval
Olympus received clearance and approval for cloud-based AI endoscopy devices in the U.S. and Europe, marking a significant milestone in enhancing clinical outcomes and operational efficiency in endoscopy.
Elevate Program Progress
Progress on the Elevate program has been very good, with over 95% of commitments to the FDA completed, including successful third-party audits and the transition to a global complaint handling system.
---
JP:7733 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
JP:7733 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 08, 2024 | ¥2697.00 | ¥2659.50 | -1.39% |
| Aug 07, 2024 | ¥2327.00 | ¥2424.00 | +4.17% |
| May 10, 2024 | ¥2282.00 | ¥2289.00 | +0.31% |
| Feb 14, 2024 | ¥2115.43 | ¥2082.70 | -1.55% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Olympus Corp. (JP:7733) report earnings?
Olympus Corp. (JP:7733) is schdueled to report earning on Feb 07, 2025, TBA Not Confirmed.
What is Olympus Corp. (JP:7733) earnings time?
Olympus Corp. (JP:7733) earnings time is at Feb 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Olympus Corp. stock?
The P/E ratio of Olympus is N/A.
What is JP:7733 EPS forecast?
JP:7733 EPS forecast for the fiscal quarter 2025 (Q3) is 35.82.
---